20 May 2013
Keywords: Pfizer, Xiapex, Dupuytren's contracture, Germany, IQWiG, AMNOG
Article | 14 February 2012
In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 February 2012
15 February 2012
17 May 2013
© 2013 thepharmaletter.com